EAM
CHE icon

Eukles Asset Management’s Chemed CHE Stock Holding History

Eukles Asset Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Sell
4,634
-1,422
-23% -$609K 0.78% 42
2025
Q4 		$2.59M Buy
6,056
+25
+0.4% +$10.9K 1.01% 34
2025
Q3 		$2.7M Buy
6,031
+24
+0.4% +$10.9K 1.05% 31
2025
Q2 		$2.93M Sell
6,007
-12
-0.2% -$6.84K 1.2% 29
2025
Q1 		$3.7M Sell
6,019
-172
-3% -$97.8K 1.63% 17
2024
Q4 		$3.28M Sell
6,191
-366
-6% -$206K 1.4% 25
2024
Q3 		$3.94M Sell
6,557
-128
-2% -$72.6K 1.58% 19
2024
Q2 		$3.63M Sell
6,685
-61
-0.9% -$34.9K 1.57% 19
2024
Q1 		$4.33M Buy
6,746
+100
+2% +$60.8K 1.88% 15
2023
Q4 		$3.89M Sell
6,646
-50
-0.7% -$28K 1.84% 16
2023
Q3 		$3.48M Buy
6,696
+45
+0.7% +$23.4K 1.84% 16
2023
Q2 		$3.6M Sell
6,651
-23
-0.3% -$12.6K 1.84% 17
2023
Q1 		$3.59M Sell
6,674
-85
-1% -$43.3K 1.95% 14
2022
Q4 		$3.45M Sell
6,759
-296
-4% -$144K 2.01% 14
2022
Q3 		$3.08M Sell
7,055
-128
-2% -$61.6K 2.02% 13
2022
Q2 		$3.37M Sell
7,183
-14
-0.2% -$6.83K 2.13% 13
2022
Q1 		$3.65M Sell
7,197
-163
-2% -$78.2K 1.98% 13
2021
Q4 		$3.89M Buy
7,360
+73
+1% +$35K 1.88% 17
2021
Q3 		$3.39M Buy
7,287
+377
+5% +$178K 1.85% 16
2021
Q2 		$3.28M Buy
6,910
+242
+4% +$116K 1.82% 16
2021
Q1 		$3.07M Buy
6,668
+372
+6% +$182K 1.98% 16
2020
Q4 		$3.35M Buy
6,296
+48
+0.8% +$23.6K 2.32% 12
2020
Q3 		$3M Buy
6,248
+40
+0.6% +$19.6K 2.34% 12
2020
Q2 		$2.8M Buy
6,208
+204
+3% +$91.1K 2.38% 11
2020
Q1 		$2.6M Sell
6,004
-287
-5% -$128K 2.71% 7
2019
Q4 		$2.76M Sell
6,291
-63
-1% -$26.5K 2.25% 12
2019
Q3 		$2.65M Sell
6,354
-33
-0.5% -$13.5K 2.3% 10
2019
Q2 		$2.31M Sell
6,387
-31
-0.5% -$10.4K 2% 14
2019
Q1 		$2.05M Sell
6,418
-16
-0.2% -$4.91K 1.87% 15
2018
Q4 		$1.82M Buy
+6,434
New +$1.94M 1.9% 15

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Eukles Asset Management's CHE Position: Q1 2026 in Review

Eukles Asset Management reduced its Chemed (CHE) stake by 23% in Q1 2026, selling an estimated $609K and leaving 4,634 shares worth $1.75M. The position accounts for 0.78% of the portfolio, ranked #42.

Eukles Asset Management first reported a position in CHE in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.33M in Q1 2024. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Eukles Asset Management held 4,634 shares of Chemed worth $1.75M as of Q1 2026.
  • Eukles Asset Management sold 1,422 Chemed shares in Q1 2026, an estimated $609K.
  • Chemed made up 0.78% of Eukles Asset Management's portfolio in Q1 2026, its #42 holding.
  • Eukles Asset Management first reported a position in Chemed in Q4 2018 and has held it in 30 quarters since.
  • Eukles Asset Management's Chemed position peaked at $4.33M in Q1 2024.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Eukles Asset Management's 13F filing for Q1 2026, filed 5 May 2026.